Abstract :
After thoroughly surveying literature, it was evident that there are few analytical methods reporting for the estimation of ramipril and olmesartan medoximil by reverse phase HPLC method. At present the new formulation ramipril and olmesartan medoximil is obtained in the market. At present, there is no specific and economical method determination of ramipril and olmesartan medoximil in a combined pharmaceutical dosage form. So there arises a need for developing a sensitised analytical method for the simultaneous estimation of ramipril and olmesartan medoximil in many pharmaceutical dosage forms which are commonly obtained in the market.
Keyword :
Ramipril, Olmesartan Medoximil, RP-HPLC, Tablets.